Why the study?
Does perioperative goal-directed therapy decrease complications and risk of death in high-risk patients undergoing noncardiac surgery?
Does perioperative goal-directed therapy decrease complications and risk of death in high-risk patients undergoing noncardiac surgery?
Perioperative goal-directed therapy using cardiac output monitoring and fluid responsiveness optimization reduces complications and mortality in high-risk noncardiac surgical patients.
May support perioperative goal-directed therapy in high-risk noncardiac surgery; leaves open confirmation by higher-level evidence.
Perioperative hemodynamic optimization, or goal-directed therapy (GDT), has been show to significantly decrease complications and risk of death in high-risk patients undergoing noncardiac surgery. An important aim of GDT is to prevent an imbalance between oxygen delivery and oxygen consumption in order to avoid the development of multiple organ dysfunction. The utilization of cardiac output monitoring in the perioperative period has been shown to improve outcomes if integrated into a GDT strategy. GDT guided by dynamic predictors of fluid responsiveness or functional hemodynamics with minimally invasive cardiac output monitoring is suitable for the majority of patients undergoing major surgery with expected significant volume shifts due to bleeding or other significant intravascular volume losses. For patients at higher risk of complications and death, such as those with advanced age and limited cardiorespiratory reserve, the addition of dobutamine or dopexamine to the treatment algorithm, to maximize oxygen delivery, is associated with better outcomes.
No takes yet. Share an insight, caveat, or question.
Lobo et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: